Products currently marketed through the Noven/JDS sales infrastructure consist of Pexeva(R) (paroxetine mesylate) and Lithobid(R) (lithium carbonate). ...
all 23 news articles
Products currently marketed through the JDS psychiatry sales infrastructure include Pexeva(R) (paroxetine mesylate) and Lithobid(R) (lithium carbonate). ...
... panic disorder, obsessive-compulsive disorder and generalized anxiety disorder) and Lithobid (for bipolar disorder and related manic episodes) to hit ...
Looking ahead to the second half of 2007, Noven expects net sales of Pexeva and Lithobid of $14 million and the company would recognize approximately $12 ...
JDS sells Lithobid for bipolar disorder and Pexeva for depression, panic disorder and obsessive-compulsive disorder. It has applied to market the capsule ...
Looking ahead to the second half of 2007, Noven expects net sales of Pexeva and Lithobid of $14 million and the company would recognize approximately $12 ...
In addition, the JDS acquisition will add Lithobid, the only branded lithium carbonate product sold in the US for bipolar disorder to Noven's portfolio. ...
... panic disorder, obsessive-compulsive disorder and generalized anxiety disorder) and Lithobid (for bipolar disorder and related manic episodes) to hit ...
New York City-based JDS markets two branded prescription psychiatry products, Lithobid and Pexeva for bipolar disporder and depression, respectively. ...